Placebo for AMG 133
Sponsors
Amgen Inc.
Conditions
"Moderate to severe obstructive sleep apnea (OSA) in adults living with overweight or obesity"Overweight and ObesityType 2 Diabetes Mellitus
Phase 2
A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus.
CompletedCTIS2023-510470-13-00
Start: 2023-03-10End: 2025-10-14Target: 135Updated: 2026-01-26
A Phase 2 Randomized, Double-blind, Placebo‑controlled, Dose‑ranging Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Subjects With Type 2 Diabetes Mellitus
Active, not recruitingCTIS2024-513539-25-00
Start: 2024-11-22Target: 169Updated: 2025-09-25